Literature DB >> 26915520

Consequences of the Diagnostic Criteria Proposed for the ICD-11 on the Prevalence of PTSD in Children and Adolescents.

Cedric Sachser1, Lutz Goldbeck1.   

Abstract

In 2013, a working group of the World Health Organization (WHO) proposed a reformulation of the posttraumatic stress disorder (PTSD) diagnostic criteria for the upcoming 11(th) edition of the International Classification of Diseases (ICD-11; Maercker, Brewin, Bryant, Cloitre, van Ommeren, et al., 2013). This study investigated the consequences of the proposed ICD-11 PTSD symptom reduction on the prevalence of PTSD in children and adolescents. Prevalence rates of PTSD in a clinical sample of 159 traumatized children and adolescents were compared applying criteria according to the 4(th) edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American Psychiatric Association, 1994), the ICD-10 (WHO, 1992), and the ICD-11. The prevalence rate was 76.1% using DSM-IV, 88.1% using ICD-10, and 61.0% using ICD-11. The use of the criteria proposed for ICD-11 resulted in 27.1% less positive cases compared with ICD-10 and 15.1% less positive cases compared with DSM-IV. Our results showed that in a clinical sample of children and adolescents the prevalence of PTSD was significantly affected by the use of different diagnostic systems. This will constitute a major challenge for research and practice because, depending on the algorithm used, different groups of patients will be included in studies and different groups of individuals will be able to access medical care and therapy.
Copyright © 2016 International Society for Traumatic Stress Studies.

Entities:  

Mesh:

Year:  2016        PMID: 26915520     DOI: 10.1002/jts.22080

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  6 in total

1.  Comparing the dimensional structure and diagnostic algorithms between DSM-5 and ICD-11 PTSD in children and adolescents.

Authors:  Cedric Sachser; Lucy Berliner; Tonje Holt; Tine Jensen; Nathaniel Jungbluth; Elizabeth Risch; Rita Rosner; Lutz Goldbeck
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-07-31       Impact factor: 4.785

2.  Prevalence of post-traumatic stress disorder among Palestinian children and adolescents exposed to political violence: A systematic review and meta-analysis.

Authors:  Nisreen Agbaria; Stephanie Petzold; Andreas Deckert; Nicholas Henschke; Guido Veronese; Peter Dambach; Thomas Jaenisch; Olaf Horstick; Volker Winkler
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

3.  Validation of the International Trauma Questionnaire-Child and Adolescent Version (ITQ-CA) in a Chinese mental health service seeking adolescent sample.

Authors:  G W K Ho; H Liu; T Karatzias; P Hyland; M Cloitre; B Lueger-Schuster; C R Brewin; C Guo; X Wang; M Shevlin
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2022-08-12       Impact factor: 7.494

4.  The child and Adolescent Trauma Screen 2 (CATS-2) - validation of an instrument to measure DSM-5 and ICD-11 PTSD and complex PTSD in children and adolescents.

Authors:  Cedric Sachser; Lucy Berliner; Elizabeth Risch; Rita Rosner; Marianne S Birkeland; Rebekka Eilers; Gertrud S Hafstad; Elisa Pfeiffer; Paul L Plener; Tine K Jensen
Journal:  Eur J Psychotraumatol       Date:  2022-08-01

Review 5.  Changes from ICD-10 to ICD-11 and future directions in psychiatric classification
.

Authors:  Wolfgang Gaebel; Johannes Stricker; Ariane Kerst
Journal:  Dialogues Clin Neurosci       Date:  2020-03       Impact factor: 5.986

6.  Prevalence and predictive value of ICD-11 post-traumatic stress disorder and Complex PTSD diagnoses in children and adolescents exposed to a single-event trauma.

Authors:  Rachel Elliott; Anna McKinnon; Clare Dixon; Adrian Boyle; Fionnuala Murphy; Theresa Dahm; Emma Travers-Hill; Cari-Lène Mul; Sarah-Jane Archibald; Patrick Smith; Tim Dalgleish; Richard Meiser-Stedman; Caitlin Hitchcock
Journal:  J Child Psychol Psychiatry       Date:  2020-04-28       Impact factor: 8.265

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.